Avectas to Present at Cell and Gene Meeting on the Mesa Conference

October 12, 2020

Avectas featured in TTP Healthcare Blog – ‘Special Delivery: can advanced…’

July 15, 2020

Avectas to Present at the OCTS Conference

July 7, 2020

Avectas and UC Davis Collaborate on Cell Engineering Technology

June 8, 2020

Avectas recognised in the Tracxn ‘Soonicorn Club 2020: Top Tech Startups In Ireland’

May 15, 2020

Avectas and ONK Therapeutics to develop off-the shelf cancer therapy

May 6, 2020

Avectas Completes Significant Series C Funding Bringing Total Invested Equity to Over $40 Million

April 16, 2020

Avectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office

April 8, 2020

Avectas featured in Genetic Engineering and Biotech News – ‘Cell and Gene Therapy Sector Needs to Automate’

April 8, 2020

Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies

March 24, 2020

Avectas and CCRM Announce Collaboration to Accelerate Development of Novel Technology for Cell Therapies

March 3, 2020

Avectas featured in 2020 Year Book of Irish Pharma Chem

February 5, 2020

Avectas joins the new Competence Center for Next-Generation NK Cell-based Cancer Immunotherapy

January 16, 2020

Avectas to Participate in PHACILITATE Webinar

November 26, 2019

Avectas recognised as ‘15 Most Promising Biotech Startup’

November 14, 2019

Avectas Raises $10 Million in Equity Finance

April 9, 2019

Avectas named ‘Bio Science Lab of the Year’ at The Irish Laboratory Awards 2019

March 7, 2019

Avectas shortlisted in the ‘US- Ireland Research Innovation Awards’

March 7, 2019

Maynooth team secures €2.1m EU funding for cancer therapy

March 20, 2018